HIV/AIDS in China

APLA Health Opens Registration for First-Ever Digital AIDS Walk Los Angeles

Retrieved on: 
Monday, July 13, 2020

Los Angeles, July 12, 2020 (GLOBE NEWSWIRE) -- Today, APLA Health opened registration for its first-ever online only, digital AIDS Walk Los Angeles.

Key Points: 
  • Los Angeles, July 12, 2020 (GLOBE NEWSWIRE) -- Today, APLA Health opened registration for its first-ever online only, digital AIDS Walk Los Angeles.
  • Digital participants will choose their walk from APLA Healths three primary service categories Care, Support, and Education.
  • AIDS Walk Los Angeles is the pioneer fundraising walk against HIV, raises vital funds, and builds support and awareness of the continuing need to address the HIV/AIDS epidemic.
  • Since 1985, hundreds of thousands of walkers and supporters have raised nearly $90 million in the fight against HIV/AIDS in Los Angeles County.To register for AIDS Walk Los Angeles or for more information, please visit: www.aidswalkla.org
    About AIDS Walk Los Angeles: Since 1985, AIDS Walk Los Angeles has drawn hundreds of thousands of supporters to walk, and millions more to donate, raising nearly $90 million to combat HIV and AIDS.

Greater Than AIDS, With Support From Walgreens and OraSure Technologies, to Provide 10,000 Free In-Home HIV Tests to Community Partners

Retrieved on: 
Thursday, June 25, 2020
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200625005666/en/
    Greater Than AIDS will provide 10,000 free in-home HIV tests to community partners.
  • Greater Than AIDS and Walgreens will also provide community partners with informational materials and digital promotions to support awareness and outreach.
  • For more about the Greater Than AIDS/Walgreens National HIV Community Partnership and other efforts to expand HIV testing, go to: greaterthan.org/walgreens .
  • Since 2011, the Greater Than AIDS/Walgreens National HIV Community Partnership has joined with health departments and HIV service organizations across the country to provide more than 57,000 free HIV tests in Walgreens stores in support of National HIV Testing Day (NHTD).

New progress in the fight to end HIV in Canada by 2025

Retrieved on: 
Tuesday, May 26, 2020

The Positive Effect collaboratively designed by scientists, medical experts, community leaders and people with living with HIV in Canada begins online at positiveeffect.org .

Key Points: 
  • The Positive Effect collaboratively designed by scientists, medical experts, community leaders and people with living with HIV in Canada begins online at positiveeffect.org .
  • HIV stigma arises out of fear, lack of knowledge, and prejudices, and thats why we created The Positive Effect.
  • Erasing stigma is a building block in our strategy to end the HIV epidemic in Canada by 2025.
  • CANFARs mission is to end Canadas HIV epidemic by leading national strategies to increase prevention, testing and linkage to care and to end HIV stigma.

HIV Drugs Market Worth $30.5 Billion in 2020 due to the Increase in Demand of HIV Drugs for the Treatment of COVID-19 Patients - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 5, 2020

The global HIV drugs market is expected to grow from $27 billion in 2019 to about $30.5 billion in 2020 due to an increase in demand for such drugs for the treatment of COVID-19 patients.

Key Points: 
  • The global HIV drugs market is expected to grow from $27 billion in 2019 to about $30.5 billion in 2020 due to an increase in demand for such drugs for the treatment of COVID-19 patients.
  • North America was the largest region in the HIV drugs market in 2019.
  • It places the market within the context of the wider HIV drugs market, and compares it with other markets.
  • The novel coronavirus outbreak has augmented the growth of global HIV drugs market.

Global HIV and AIDS Drug Market (2020 to 2025) - by Manufacturers, Regions, Technology & Product Type - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 14, 2020

The "HIV and AIDS Drug Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology, Product Type" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "HIV and AIDS Drug Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology, Product Type" report has been added to ResearchAndMarkets.com's offering.
  • This report is a professional and in-depth study on the current state of the global HIV and AIDS Drug market with a focus on the Chinese market.
  • Key points of HIV and AIDS Drug Market Report:
    The report provides a basic overview of HIV and AIDS Drug industry including: definition, applications and manufacturing technology.
  • Overall, the report provides an in-depth insight of 2015-2025 global and Chinese HIV and AIDS Drug market covering all important parameters.

AHF: Resources Needed for Gov’t Plan to End HIV Epidemic

Retrieved on: 
Thursday, February 27, 2020

Governments Ending the HIV Epidemic: A Plan for America ( EHE ) that President Trump announced in his February 5, 2019 State of the Union address to the U.S. Congress.

Key Points: 
  • Governments Ending the HIV Epidemic: A Plan for America ( EHE ) that President Trump announced in his February 5, 2019 State of the Union address to the U.S. Congress.
  • Yet one year later, based on a survey of its HIV primary care out-patient health care centers, little of the HIV prevention and treatment landscape has changed.
  • But this goal cant be achieved until resources are scaled up to meet the targets in the plan.
  • HIV Surveillance Report: Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data, United States and 6 Dependent Area, 2017.

2020 Global HIV/AIDS Diagnostics Market: US, Japan, France, Germany, Italy, Spain & the UK - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 29, 2020

The "2020 Global HIV/AIDS Diagnostics Market: US, Europe, Japan - Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2020 Global HIV/AIDS Diagnostics Market: US, Europe, Japan - Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies" report has been added to ResearchAndMarkets.com's offering.
  • The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan.
  • Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed.
  • The report provides the 5-year test volume and sales forecasts by country for HIV-1/2/Combo, HIV Ag, HTLV-I/II, Western Blot and other confirmatory tests performed in the following markets:

North America HIV Drugs Market: Trends, Share, Size, Growth, Opportunity and Forecast (2019-2024) - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 2, 2020

The "North America HIV Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "North America HIV Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.
  • This report provides a deep insight into the North America HIV drugs market covering all its essential aspects.
  • How has the North America HIV drugs market performed so far and how will it perform in the coming years?
  • What is the breakup of the North America HIV drugs market on the basis of drug class?

HIV CARE PROVIDERS IDENTIFY THE TOP BARRIERS TO ENDING THE EPIDEMIC

Retrieved on: 
Wednesday, December 11, 2019

Washington, DC, Dec. 11, 2019 (GLOBE NEWSWIRE) -- The American Academy of HIV Medicine (AAHIVM), today, highlighted critical barriers to ending the HIV epidemic as identified by HIV care providers in the hardest hit areas of the country.

Key Points: 
  • Washington, DC, Dec. 11, 2019 (GLOBE NEWSWIRE) -- The American Academy of HIV Medicine (AAHIVM), today, highlighted critical barriers to ending the HIV epidemic as identified by HIV care providers in the hardest hit areas of the country.
  • Providers cite homelessness/unstable housing, HIV stigma, and transportation barriers as the three biggest barriers to care.
  • In urban jurisdictions where there is an historical HIV epidemic, clinicians believe their community is faring better across the HIV care continuum, there are more providers available to treat people with HIV and provide PrEP, and there are fewer barriers to care.
  • The American Academy of HIV Medicine is the nations leading independent organization of healthcare professionals dedicated to providing excellence in HIV care and prevention.

Gilead Sciences COMPASS Initiative™ Awards Over $2.3M to 40 Organizations Fighting HIV in the South

Retrieved on: 
Thursday, December 5, 2019

The three organizations are the Coordinating Centers of Gilead Sciences' COMPASS Initiative (COMPASS), which identified grantees engaged in community-driven solutions that are improving the health and well-being of those impacted by HIV in the South.

Key Points: 
  • The three organizations are the Coordinating Centers of Gilead Sciences' COMPASS Initiative (COMPASS), which identified grantees engaged in community-driven solutions that are improving the health and well-being of those impacted by HIV in the South.
  • "Together, we can find, grow and strengthen the capacity of organizations that are able to combat HIV in the Southern United States."
  • COMPASS invests in community organizations that build awareness, reduce stigma, advance education, share knowledge and promote the well-being of individuals impacted by HIV.
  • Born out of the recognition that the South is disproportionately affected by HIV, Gilead announced the COMPASS Initiative two years ago.